Journal
REDOX BIOLOGY
Volume 63, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.redox.2023.102730
Keywords
Triglycerides; Omega-3 fatty acids; Genotype; Epigenetics; Gene expression; Gut microbiota
Categories
Ask authors/readers for more resources
Cardiovascular disease is a leading cause of death worldwide. Supplementation with marine omega-3 fatty acids EPA and DHA is associated with lower CVD risk. However, results from randomized controlled trials on the effect of omega-3 supplementation on CVD risk are inconsistent.
Cardiovascular disease (CVD) is a leading cause of death worldwide. Supplementation with the marine omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is associated with lower CVD risk. However, results from randomized controlled trials that examine the effect of omega-3 supplementation on CVD risk are inconsistent. This risk-reducing effect may be mediated by reducing inflammation, oxidative stress and serum triglyceride (TG) levels. However, not all individuals respond by reducing TG levels after omega-3 supplementation. This inter-individual variability in TG response to omega-3 supplementation is not fully understood. Hence, we aim to review the evidence for how interactions between omega-3 fatty acid supplementation and genetic variants, epigenetic and gene expression profiling, gut microbiota and habitual intake of omega-3 fatty acids can explain why the TG response differs between individuals. This may contribute to understanding the current controversies and play a role in defining future personalized guidelines to prevent CVD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available